🔎 Trials Near Me

Akèy › Kansè vejik › Arizona › Gilbert

Etid klinik pou Kansè vejik nan Gilbert, AZ

6 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Gilbert (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Ap rekriteFaz 3
  • Banner MD Anderson Cancer Center, Gilbert
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07000084

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Ap rekriteFaz 2
  • Banner MD Anderson Cancer Center, Gilbert
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07061964

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Ap rekriteFaz 1/2
  • Banner MD Anderson Cancer Center, Gilbert
Laj 18 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT06814496

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Ap rekriteFaz 2
  • Banner MD Anderson Cancer Center, Gilbert
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06567743

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Ap rekriteFaz 2/3
  • Local Institution - 0167, Gilbert
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT07106762

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Ap rekriteFaz 2
  • Banner Gateway Medical Center, Gilbert
  • Banner MD Anderson Cancer Center, Gilbert
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04879329

Etid Kansè vejik nan lòt vil

Lòt etid nan Gilbert

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.